- UroToday Home
- Trials in Progress
Trials in Progress
IRONMAN PCCTC: International Registry for Men With Advanced Prostate Cancer
Trials in Progress
Videos
Publications
Articles and Abstracts
Movember Study to Test Whether Remote Monitoring Can Improve Prostate Cancer Care
Reno, Nevada (UroToday.com) -- Men with advanced prostate cancer would suffer less pain and anxiety and would be less likely to be hospitalised, if their doctors were automatically alerted to contact them when their health began to fail, a new study is aiming to show.
Read More
Read More
Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry.
Prostate cancer disproportionately affects racial and ethnic minority populations. Reasons for disparate outcomes among minority patients are multifaceted and complex, involving factors at the patient, provider, and system levels.
Read More
Conference Coverage
Conference Highlights Written by Physician-Scientist
ASCO GU 2022: First Look at Patient Reported Outcomes from IRONMAN, the International Registry of Men with Advanced Prostate Cancer
Presented by Emily Rencsok
The 2022 GU ASCO Annual meeting included a prostate cancer session highlighting work from Dr. Emily Rencsok and colleagues presenting the first results from IRONMAN, an assessment of patient reported outcomes in an international registry of men with advanced prostate cancer. Read More
APCCC19: Outcomes Research – IRONMAN Project – Preliminary Results Update
Presented by Ian Davis, MB BS PhD FRACP FAChPM
Dr. Ian Davis briefly showed some of the progress that has been made with the IRONMAN study, an International Registry for Men with Advanced Prostate Cancer. This registry also includes molecular subtyping and patient-reported outcome measures (PROMs). Read More
APCCC 2019: An Update on the IRONMAN Project
Presented by Alicia Morgans, MD
Dr. Morgans presented the IRONMAN project, which is the international registry for men with advanced prostate cancer. There are an estimated 1.3 million new cases of prostate cancer and 359,000 prostate cancer deaths globally each year. This is a rapidly evolving clinical landscape and there is variability in guidelines and clinical practice in advanced disease. Read More